Clinical Trial Update: Impact of the M22-IPL Acne Filter on Acne Vulgaris [NA]

View source ↗

Summary

A terminated clinical trial update evaluating the M22-IPL Acne Filter for acne vulgaris, sponsored by Lumenis Be Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• M22-IPL Acne Filter

Snippet

Sponsor: Lumenis Be Ltd. | Conditions: Acne | NA | Status: TERMINATED